Ketogenic Diet for Bipolar Disorder
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether a ketogenic diet (a very low carbohydrate, high-fat diet), combined with regular treatment, can enhance brain energy and reduce symptoms in individuals with bipolar disorder or schizoaffective disorder. Participants will either follow a ketogenic diet or adhere to the Dietary Guidelines for Americans, both alongside their usual medications. The trial seeks individuals diagnosed with bipolar I disorder or schizoaffective disorder within the last 7 years, who have a stable condition and have not recently changed their psychiatric medication. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could improve future treatment options.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you must have a stable psychiatric disorder with no change in psychiatric medications within the past 2 weeks before screening and should not need new psychiatric medications during the study.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that the ketogenic diet, high in fats and low in carbohydrates, can improve metabolic health. This diet shifts the body's primary energy source from carbohydrates to fats. Some studies have found that individuals on a ketogenic diet might experience changes in blood fat levels, particularly if they are taking certain antipsychotic medications.
Other research suggests that most people can follow the diet without major issues. However, monitoring blood ketone levels is important, as the diet can affect them. In one study, overweight teenagers who followed a similar diet for 12 weeks lost more weight than those on a low-fat diet, without major safety concerns.
Overall, while the ketogenic diet appears promising, following medical advice and monitoring health indicators is crucial when starting this diet.12345Why are researchers excited about this trial?
Most treatments for bipolar disorder rely on medications like mood stabilizers and antipsychotics. However, the ketogenic diet stands out because it focuses on altering metabolic processes in the body by switching the primary energy source from carbohydrates to fats, potentially impacting brain chemistry in a way that could stabilize mood. Researchers are excited about this approach because it offers a non-pharmacological option that might work alongside or even enhance the effects of traditional medications. Additionally, the diet involves daily ketone monitoring, providing real-time feedback on adherence, which could empower patients in managing their condition.
What evidence suggests that the ketogenic diet could be an effective treatment for bipolar disorder?
Research suggests that the ketogenic diet, high in fat and low in carbohydrates, might improve symptoms in people with bipolar disorder. Studies have found that this diet can lead to positive changes in the body, such as better weight control and improved insulin use, which might enhance mental health. In this trial, participants in the ketogenic diet arm will follow this diet for 12 weeks, while those in the Dietary Guidelines for Americans arm will adhere to standard dietary guidelines. A small study found that people with severe mental illness who tried the ketogenic diet reported feeling better. Although more research is needed, these early results suggest that the ketogenic diet could be a promising way to manage bipolar disorder.678910
Who Is on the Research Team?
Virginie-Anne Chouinard, MD
Principal Investigator
Mclean Hospital
Are You a Good Fit for This Trial?
This trial is for individuals experiencing their first episode of bipolar disorder or schizoaffective disorder. Participants should be willing to follow specific dietary guidelines, including a ketogenic diet as part of the study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants follow either a ketogenic diet or the Dietary Guidelines for Americans for 12 weeks, with weekly diet counseling and daily blood ketone monitoring
Follow-up
Participants are monitored for safety and effectiveness after treatment
Open-label extension (optional)
Participants may opt into continuation of the ketogenic diet with daily blood ketone monitoring for an additional 12 weeks
What Are the Treatments Tested in This Trial?
Interventions
- Ketogenic diet
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mclean Hospital
Lead Sponsor
Baszucki Family Foundation
Collaborator